Glutathione reverses endothelial damage from peroxynitrite, the byproduct of nitric oxide degradation, in crystalloid cardioplegia

Citation
M. Nakamura et al., Glutathione reverses endothelial damage from peroxynitrite, the byproduct of nitric oxide degradation, in crystalloid cardioplegia, CIRCULATION, 102(19), 2000, pp. 332-338
Citations number
32
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
CIRCULATION
ISSN journal
00097322 → ACNP
Volume
102
Issue
19
Year of publication
2000
Supplement
S
Pages
332 - 338
Database
ISI
SICI code
0009-7322(20001107)102:19<332:GREDFP>2.0.ZU;2-Z
Abstract
Background-NO has been advocated as an adjunct to cardioplegia solutions. H owever, NO undergoes a rapid biradical reaction with superoxide anions to p roduce peroxynitrite (ONOO-). ONOO- in crystalloid cardioplegia solution in duces injury to coronary endothelium and to systolic function after cardiop legia and reperfusion. However, ONOO- may be degraded to less lethal or car dioprotective intermediates with glutathione (GSH) in reactions separate fr om its well known antioxidant effects. We hypothesized that GSH detoxifies ONOO- and reverses defects in endothelial function and systolic function wh en present in crystalloid cardioplegia. Methods and Results-In anesthetized dogs on cardiopulmonary bypass, a 45-mi nute Period of global normothermic ischemia was followed by 60 minutes of i ntermittent cold crystalloid cardioplegia (Plegisol) and 3 hours of reperfu sion. The cardioplegia solution contained 5 mu mol/L authentic ONOO-; catal ase was included to attenuate the potential antioxidant effects of GSH and to unmask the effects on ONOO-. In 1 group (CP+GSH, n=5), the cardioplegia contained 500 mu mol/L GSH, whereas 1 group received crystalloid cardiopleg ia without CSII (CCP, n=6). There were no group differences in postcardiopl egia left ventricular systolic function (end-systolic pressure-volume relat ion, impedance catheter: CCP 10.0+/-2.4 versus CP+GSH 10.6+/-1.3 mmHg/mL) o r diastolic chamber stiffness (beta -coefficient. CCP 0.35+/-0.2 versus CPGSH 0.31+/-0.18). Myocardial neutrophil accumulation (myeloperoxidase activ ity) was attenuated in CP+GSH versus CCP (2.2+/-0.7 versus 5.4+/-1.2, P<0.0 5). In postexperimental coronary arteries, maximal endothelium-dependent re laxation was greater in CP+GSH than in CCP (118+/-6% versus 92+/-5%, P<0.05 ), with a smaller EC,, value (-7.10+/-0.05 versus -6.98+/-0.03, respectivel y, P<0.05). Smooth muscle relaxation was complete in both groups. The adher ence of neutrophils to postexperimental coronary arteries as a measure of e ndothelial function was less in CP+GSH than in CCP (98+/-18 versus 234+/-36 neutrophils/mm(2), P<0.05). Nitrosoglutathione, a byproduct of the reactio n between ONOO- and GSH, was greater in CP+GSH than in CCP (4.1+/-2.3 versu s 0.4+/-0.2 mug/mL, P<0.05). Conclusions-GSH in crystalloid cardioplegia detoxifies ONOO- and forms card ioprotective nitrosoglutathione, resulting; in attenuated neutrophil adhere nce and selective endothelial protection through the inhibition of neutroph il-mediated damage.